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Abstract: Antibiotic prescribing in England varies considerably between Clinical Commissioning
Groups (CCGs) and general practices. We aimed to assess social and contextual factors
affecting antibiotic prescribing and engagement with antimicrobial stewardship (AMS) initiatives.
Semi-structured telephone interviews were conducted with 22 CCG professionals and 19 general
practice professionals. Interviews were audio-recorded, transcribed, and analyzed thematically.
Social/contextual influences were grouped into the following four categories: (1) Immediate context, i.e.,
patients’ social characteristics (e.g., deprivation and culture), clinical factors, and practice and clinician
characteristics (e.g., “struggling” with staff shortage/turnover) were linked to higher prescribing.
(2) Wider context, i.e., pressures on the healthcare system, limited resources, and competing priorities
were seen to reduce engagement with AMS. (3) Collaborative and whole system approaches, i.e.,
communication, multidisciplinary networks, leadership, and teamwork facilitated prioritizing AMS,
learning, and consistency. (4) Relativity of appropriate prescribing, i.e., “high” or “appropriate”
prescribing was perceived as relative, depending on comparators, and disregarding different contexts,
but social norms around antibiotic use among professionals and patients seemed to be changing.
Further optimization of antibiotic prescribing would benefit from addressing social/contextual
factors and addressing wider health inequalities, not only targeting individual clinicians. Tailoring
and adapting to local contexts and constraints, ensuring adequate time and resources for AMS,
and collaborative, whole system approaches to promote consistency may help promote AMS.
Keywords: antibiotic prescribing; antimicrobial stewardship; primary care; qualitative
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1. Introduction
Overuse of antibiotics is one of the main contributors to antimicrobial resistance. Because most
antibiotics in England are used in the community [1], many with no benefit to patients, more prudent
prescribing in primary care is needed. Many different antimicrobial stewardship (AMS) initiatives
have been used to optimize antibiotic prescribing in primary care [2,3]. AMS strategies are frequently
targeted directly at and provided to individual prescribers (e.g., diagnostic scores and training) and
some have been implemented nationally (e.g., prescribing targets). For example, the Quality Premium
(QP) is an incentive scheme to improve the quality of primary care services in England and has
included targets for Clinical Commissioning Groups (CCGs) to optimize antibiotic prescribing [4].
The CCGs are organizations responsible for commissioning and ensuring quality of primary care
services in the English National Health Service (including funding and monitoring the quality of
services offered in general practices). The introduction of the QP antibiotic targets was associated with
reductions in antibiotic prescribing [5,6], and over 83% of CCGs (between 2015 and 2018) met the QP
targets for reducing total and broad-spectrum antibiotic prescribing in primary care [4]. However,
not all CCGs and general practices reduced antibiotic prescribing at the same rate or met the QP
targets. There was also considerable overall variation in the volume of antibiotic prescribing [7–12], i.e.,
two-fold differences between the lowest- and highest-prescribing CCGs (2010–2017) [7] and general
practices (2004–2005) [12].
Some variation in antibiotic prescribing can be explained by patient-related factors, such as
comorbidities, smoking, age, weight, ethnicity, or socioeconomic status [7,8,10,12]. However,
substantial variation between practices remains even after accounting for comorbidities, smoking,
and deprivation [9,10]. Higher antibiotic prescribing has been associated with practice characteristics,
such as location (north of England, rural), deprivation, larger practice size, or high consultation rates
for respiratory infections [7–9,11–13]. Differences in antibiotic prescribing may also be associated with
prescribers’ characteristics (e.g., higher prescribing by male, older GPs and those qualified outside the
UK) [12].
Antibiotic prescribing is undoubtedly influenced by individual-level factors, both patient-related
(e.g., clinical presentation, history, and comorbidities) and clinician-related (e.g., knowledge of
guidelines, experience, and risk tolerance). However, these are not the only influences. There have
been increasing calls to recognize and address social and contextual influences on antibiotic prescribing
and AMS [14,15]. Antibiotic prescribing is a process influenced by the interaction between individuals
and the social and physical environment [15], and antimicrobial resistance is “deeply social, shaped
by cultural, political, and economic processes” so it requires a social solution (p.1) [14]. A review of
international, qualitative studies on general practitioners’ (GPs) experiences of antibiotic prescribing
for acute respiratory tract infections (RTIs) concluded that clinicians are influenced by the intrapersonal,
interpersonal, and contextual situation [16]. The examples of contextual influences included considering
patient retention and financial factors, medico-legal issues (i.e., concerns about being sued for “missing
something” in a patient), continuity of care, work pressure and fatigue, over-the-counter access to
antibiotics, lack of consistent national guidelines, and incentives from the pharmaceutical industry [16].
When comparing views of prescribers from low- and high-prescribing practices in England, some of the
differences in contextual influences on antibiotic prescribing included perceptions of others’ prescribing
and support for no-antibiotic decisions, consultation length, triage system, access to microbiologists or
pharmacists, and (for all practices) consequences of complaints or adverse events [17]. While several
qualitative studies have described influences on antibiotic prescribing, some of which are contextual,
they have not specifically explored how social and contextual factors influence engagement with
AMS interventions.
We aimed to describe which social and contextual influences were perceived by CCG professionals
and general practice professionals as impacting on antibiotic prescribing and engagement with AMS,
and how they impacted on antibiotic prescribing. This qualitative study was conducted with the overall
aim to understand the implementation and mechanisms of the QP and related AMS interventions
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(reported previously [18]), as part of a larger study on improving implementation of AMS interventions
(“STEP-UP” [19]).
2. Methods
2.1. Study Participants
CCG professionals responsible for AMS were identified from a list of contacts for all CCG
Medicines Management/Optimisation teams. The initial recruitment used purposeful sampling to
ensure diverse CCG characteristics (antibiotic prescribing rates, location, deprivation, and number
of GP practices). However, due to a low response rate, eventually all 145 contacts were emailed
study invitations. From the participating CCGs, 12 diverse CCGs were selected; within each CCG,
practices with the highest and lowest antibiotic prescribing rates (top/bottom 25%) were selected,
and 162 practices were invited. Invitations were sent by email or post, and non-responders were
followed up twice. Participants were asked to return signed consent forms or give verbal consent
which was recorded. The study was approved by the University of Oxford’s research ethics committee
(ref. R53960) and the Health Research Authority (ref. 230479).
2.2. Data Collection
Telephone interviews were conducted by the first author (A.B., a sociologist and experienced
qualitative researcher) between December 2017 and September 2018 using two semi-structured topic
guides; one for CCG and one for practice professionals (Supplementary Materials). In brief, participants
were asked about their role in addressing AMS, views on AMS and the QP, how they decided to
address antibiotic prescribing targets, how they communicate within and between CCGs and general
practices, and suggestions related to the QP and AMS. Open questions were followed with prompts to
gather further detail. Participants were offered 40 GBD shopping vouchers or payment to their practice
for their participation. The interviews were audio-recorded, transcribed verbatim, and transcripts
were then checked for accuracy and anonymized.
2.3. Data Analysis
Interview transcripts were uploaded to NVivo software (v.11) and analyzed thematically [20].
One researcher (A.B.) coded all transcripts inductively line-by-line. Three researchers (S.A., R.A.,
S.T.C.) double-coded 20 transcripts (6–7 transcripts each), making notes on the key topics and potential
themes. The analysis (i.e., coding, developing categories, and themes) was discussed with the team,
and the codes and categories were refined and defined. The key themes (i.e., those that addressed the
research question and were supported by the data) were identified, discussed, and agreed on with the
study team. After analyzing the CCG and practice interviews separately, the findings were compared
and combined into one integrated framework, with attention to similarities and disparities.
3. Results
Twenty-two CCG professionals and 19 general practice professionals were interviewed (Table 1).
The CCG professionals worked across 33 CCGs, with four working across multiple CCGs. The CCGs
and practices were diverse in terms of antibiotic prescribing rates, deprivation, and number of practices
and prescribers. The interviews with CCG professionals lasted 35 to 65 (mean 52) minutes and with
practice professionals 26 to 57 (mean 40) minutes. The overarching theme was social and contextual
influences. Below, we describe the four categories of these influences (summarized in Figure 1) and
how they were perceived to influence antibiotic prescribing and AMS. Additional quotes illustrating
the findings are available in Supplementary Materials.
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Table 1. Sample characteristics.
Characteristics CCG Participants(n = 22, 33 CCGs)
General Practice Participants
(n = 19)
Sex 17 females, 5 males 9 females, 10 males
Age (years) 35–60 (mean 48) 36–68 (mean 49)
Role Leadership role, 11Team member/prescribing advisor-type role, 11
General practitioners, 14
Nurse prescribers, 3
Practice managers, 2
Years in current organization 1–20 (mean 6)
1–35 (mean 13)
General practitioners, 5–35,
Nurse prescribers, 1–5,
Practice managers, 7 and 10
Years in current role/since qualified 1–19 (mean 4)
2–45 (mean 21)
General practitioners, 8–45
Nurse prescribers, 2 and 11
Size of CCG/general practice
9–97 practices (mean 40)
Small (<25 practices), 10 CCGs
Medium (25–75 practices), 20 CCGs
Large (>76 practices), 3 practices
2–24 prescribers (mean 9)
Small (2–5 prescribers), 7 practices
Medium (6–15 prescribers), 11 practices
Large (>20 prescribers), 1 practice
Deprivation 1
High (1–3 decile), 6 CCGs
Medium (4–7 decile), 12 CCGs
Low (8–10 decile), 15 CCGs
High (1–3 decile), 8 practices
Medium (4–7 decile), 7 practices
Low (8–10 decile): 4 practices
Antibiotic prescribing rates 2
(items/STAR-PU)
High (quintiles 4–5), 13 CCGs
Medium (quintile 3), 9 CCGs
Low (quintiles 1–2), 11 CCGs
High (>0.27), 4 practices
Medium (0.25–0.27), 7 practices
Low (<0.25), 8 practices
Notes: 1 Deprivation was based on the Index of Multiple Deprivation decile in England (2015); “high” deprivation level was considered for deciles 1–3, “medium” for deciles 4–7, “low” for
deciles 8–10. 2 For CCGs, based on the PrescQIPP antibiotic prescribing data (items per STAR-PU for year 2017), the CCGs in the 1st or 2nd quintile of antibiotic prescribing in England
were considered to be “low”, the CCGs in the 3rd quintile were considered to be “medium”, and the CCGs in the 4th or 5th quintile were considered to be “high”. For general practices,
based on Fingertips data (items/STAR-PU for quarter 4, 2017), general practices with antibiotic prescribing rates under 0.25 were considered to be “low”, between 0.25 and 0.27 were
considered to be “medium”, and over 0.27 were considered to be “high’. STAR-PU (specific therapeutic group age-sex related prescribing unit) is weighting used to take into account
variation in the size and nature of the patient population.
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Figure 1. Summary of social and contextual influences on antibiotic prescribing and antimicrobial
stewardship (AMS).
3.1. Immediate Context: Patient, Clinician, and Practice Characteristics
CCG professionals reported a considerable variation in antibiotic prescribing between practices,
which reflected geodemographic and socioeconomic differences influencing patient health and practice
characteristics. These complex and often historically rooted influences were seen as a challenge for
reducing antibiotic prescribing.
CCG and practice professionals described that patients in some areas had greater needs or
expectations for antibiotics. In particular, higher deprivation was perceived as contributing to higher
antibiotic prescribing by being linked to the following: more illness and comorbidities; less (ability
to) self-care and less access to over-the-counter remedies; lower threshold for GP appointments and
antibiotic treatment (i.e., patients consulting earlier in the illness, expecting antibiotics); and need for
illness validation (e.g., sick notes) and quicker recovery.
The practice is in a deprived area and the patient expectation here is that they will get a prescription
for an antibiotic. Not only that, but people live in overcrowded situations and there is cross-infection
with wider infections etc. ( . . . ) I think there may be a clinical reason but not sufficient to explain the
complete high prevalence but I feel we often get into a situation where the patient’s expectation is for a
prescription for antibiotic and when we refuse or try and explain that it’s not appropriate, we get a
very irate patient, and I can understand that because there is a pressure on the patient to get well
and get back to work as their income levels are lower in the patch we work in. Also, children with
coughs and colds, parents would expect antibiotics because their child staying at home would mean
that the parent would have to take time off work and again, loss of income. And so a patient more or
less expects a prescription. (GP-7, high-prescribing)
Patient expectations for antibiotics were generally seen as higher in more deprived areas, but
a couple of CCG participants described expectations to be higher in less deprived, smaller, rural
communities (“a reasonably affluent population who are quite demanding” (CCG-2)). Moreover,
patients from different cultural/ethnic backgrounds were described as having higher expectations for
prescriptions influenced by their health-related cultural norms, and being difficult to reassure without
medication, especially when there were also language barriers.
. . . we have a large Pakistani community and I think culturally there is this expectation that when
you go to the doctors, they’ll give you a prescription and sometimes it doesn’t even matter what that
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prescription is, but you have to have some medication and also there’s a language barrier quite often as
well . . . and some of our patients aren’t particularly well educated as well, so trying to give people
some understanding of even basic statistics or basic kind of biology is quite difficult and trying to
explain to somebody that you don’t need a prescription. (GP-10, low/medium-prescribing)
Practice and staff characteristics were also perceived as influencing antibiotic prescribing and
AMS. High-prescribing practices were described as those that “struggled as general practices” (CCG-5),
those most under-pressure and “overstretched” (CCG-9) due to staff shortages and high demand
(“utterly deluged with needing to see patients” (CCG-2)), undergoing transitions, and consequently
with more changing, temporary staff. In such practices, there seemed to be less “ownership” of
prescribing, less engagement with AMS, and higher antibiotic prescribing was seen as just one of
many challenges (these practices “don’t perform well in other areas as well, so it’s not just antibiotics”
(CCG-6)). Stable staff and patients, allowing for continuity of care, were seen as factors enabling more
appropriate prescribing.
We have good response from the practices that have stable staff. Unfortunately, there are quite a lot of
practices that have a lot of locums, transient staff, maybe inexperienced staff and what we find is that
in those areas and often areas that have high levels of chronic disease we tend to get a high prescribing
rate and it’s difficult to address that particularly when you can’t engage the staff as they’re not there
long-term. ( . . . ) There’s been a lot of retirement from practices in [area] and there’s been takeovers of
practices and as a consequence you’ve had lots of locum staff or short-term staff there. I think once
there’s less ownership of the problem, you tend to see a deterioration in the antibiotic prescribing rates.
I would argue we could map that across the city and say, we know these practices have a problem and
will continue because they are struggling as general practices and as a consequence that impacts on
their antimicrobial prescribing. (CCG-5, high-prescribing)
Participants also reported that certain types of prescribers might be more likely to overprescribe
antibiotics. They linked higher prescribing to (practices with more) locums, older GPs, non-GP
or inexperienced prescribers, or those qualified outside the UK. For example, some older GPs (i.e.,
as compared with more recently trained/qualified) were seen as having a tendency (or habit) to
prescribe more antibiotics, whereas some locums were seen as less responsible and accountable (with
less “ownership”) for their prescribing (“just want to get through their patient list” (CCG-2)), less aware
of local guidelines, and lacking helpful long-term relationships with patients.
This is a bit controversial, but there’s quite a lot of locum GPs and there’s quite a lot of older GPs . . .
some of the older GPs aren’t quite as up to date on the guidelines on what to prescribe so they tend to
prescribe drugs that they’ve prescribed a lot in the past and the guys who come as locums don’t have
that same kind of . . . it’s my permanent base so I’m very strict on what I prescribe and I stick to the
guidelines, but some of the locums don’t and because they work across different places . . . and the
guidelines may be slightly different. (GP-11, high-prescribing)
Individual-level factors were also perceived as sometimes increasing prescribing and
disengagement with AMS (e.g., unawareness of inappropriate prescribing and lacking the motivation
to change). Some higher prescribers were seen as more concerned about risks or having experience
of adverse effects, and potential malpractice accusations and legal consequences, of not prescribing
antibiotics. Therefore, some were described as prescribing defensively (i.e., in a risk-averse way) or
feeling defensive about their prescribing which precluded engagement with AMS. This reflected general
perceptions of insufficient importance of prudent antibiotic prescribing and more risk of negative
consequences (to the patient and the prescriber) of not prescribing than of prescribing antibiotics.
People’s thresholds as to what’s reasonable can be subjective so it depends on how open-minded you
are when you go into an audit. If you do an audit feeling defensive, then it’s probably a waste of
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time because you’re going to find an excuse to justify things ( . . . ) practices that are practicing
defensively or under a lot of pressure seem to be the ones that are much less likely to change. (CCG-9,
multiple CCGs)
I still don’t think there is the level of gravity placed on inappropriate prescribing. It’s still perceived
widespread as a sort of poor judgement call. If you imagine that we were prescribing drugs for diabetes
or hypertension or other long-term conditions inappropriately, it would be seen as a fairly serious
deficit in care. Whereas if it’s an antibiotic, it’s seen as poor judgement or just GPs taking the easy life.
(CCG-21, high-prescribing)
3.2. Wider Context: Pressures on the System and Resources
The wider context of the healthcare system, with many competing priorities and inadequate
resources, were perceived as hindering engagement with AMS.
For most CCG professionals, AMS constituted a small part of their roles, which limited how they
could support practices. Most considered the available resources (time, staff, and finance) insufficient
for more time- and resource-intensive AMS work (e.g., auditing prescribing in practices, delivering
face-to-face training, and offering financial incentives), although these were seen as more impactful
than less intensive strategies (e.g., emailing prescribing targets and reports and providing online data).
Similarly, practice professionals described AMS as an area of special interest for some rather than
of concern for all practice professionals. They reported large workload and demand, staff shortages,
and time pressures (including short consultations) as impeding their engagement with AMS and
prudent antibiotic prescribing. In this pressured context, seeing patients was prioritized over engaging
with AMS strategies (seen as requiring additional time), and prescribing antibiotics was seen as a way
to deal with workload/demand (i.e., as easier and quicker than not prescribing and as limiting patients
returning for antibiotics) and to help reduce workload elsewhere (e.g., in out-of-hours or emergency
services). These challenges were seen as part of a larger problem of pressures on the NHS system.
There was a sense that professionals are increasingly “tired” of the constant pressure to change practice
but without the necessary changes in the context that affects it.
The thing that everyone recognizes is that it takes so much longer to explain why you’re not prescribing
than it does to just churn out a script for an antibiotic so time is key and over-pressurized practices with
insufficient staff for the workload might be predicted to prescribe more or more often inappropriately,
possibly. I think we need to keep an eye on the staffing and workload levels because having time with
the patient is the most effective way of exploring their actual issues and what really is worrying them
. . . . (GP-18, medium/low-prescribing)
So the issue really isn’t just simply about antimicrobials. It’s about antimicrobial prescribing within a
constrained under-pressure system that in some areas is really very very delicate. Banging on and
saying messages about the antibiotic problems ahead is very hard when you’ve got everyday pressures
in general practices you’ve got to contend with and a waiting room full of people that you’ve got
to get through. [ . . . ] I think people are tired with change and tired of the relentless messages, do
this, do that. So I think at the moment if it’s going to make people’s lives harder or add to workload,
then you’re probably reducing the chances of that change happening. (CCG-9, multiple CCGs)
Thus, there was an agreement that AMS strategies need to fit within these constraints, for example,
by being easily accessible and adaptable, not requiring (much) additional work or effort, and being
concise and with clear benefits to practitioners. CCG professionals also reported the need for more
tailoring of AMS approaches to practices and local contexts to account for the different reasons for high
prescribing and variations in scope and areas for improvement. Practices were seen as diverse and
independent organizations that should be supported in ways specific to their needs. CCG professionals
thought that acknowledging and formalizing AMS as part of their roles and responsibilities, and more
time and support (e.g., administrative) would allow them to work with practices more closely (e.g.,
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visiting practices to provide training and collaboratively problem solve). Practice professionals also
thought that additional financial resources and incentives would enable clinicians to prioritize and
devote time specifically for AMS (e.g., auditing own and practice’s prescribing).
I don’t think you can have a single approach. I think if you find that somebody isn’t following what
you think is sensible advice, you need to go and have a conversation with them to understand what the
barriers are to implement the advice that you think is sensible. Usually those barriers will have some
substance. You then have to look at what the barriers are, you have to work out whether it’s possible to
move those barriers. (CCG-8, low-prescribing)
3.3. Collaborative and Whole System Approaches
Participants stressed the importance of collaboration, effective communication, and leadership
within organizations and across professional networks and settings. They recommended a whole
system approach to AMS to promote greater consistency in antibiotic prescribing.
While the amount and ways of communicating varied largely within and between organizations,
participants highlighted the importance of regular, effective communication. Interactive discussions,
especially involving collaboratively identifying and addressing issues, were seen as challenging due to
time constraints but more effective than passive communication (e.g., email newsletters). Participants
described the value of discussing antibiotic prescribing within practice teams and between practices
(e.g., in locality meetings), as well as within and between CCGs, which enabled sharing and learning
from each other (e.g., about helpful strategies) and more consistent approaches.
Sharing experience, sharing best practices and helping clinicians who are struggling is the only way.
We already have a severe workforce crisis, we can’t have a GP leaving because they can’t deal with
that. (GP-15, low-prescribing)
I’d love to learn from those that have done really well and how they’ve achieved it because there is such
a difference particularly with the London practices, I don’t know how they’re doing it. ( . . . ) It would
be really interesting just to know how people have done it. (CCG-4, high-prescribing)
Participants discussed the importance of being connected and working with local networks.
For CCG professionals, networks were often multidisciplinary and included GPs, hospital staff,
microbiologists, pharmacists, out-of-hours providers, and other CCG teams (e.g., quality teams);
for practice professionals, networks were with other local practices, microbiologists, and pharmacists.
Poor communication with peers and networks and fragmentation of healthcare organizations were
seen as barriers to AMS, whereas more teamwork, connectedness, and collaboration across networks
and settings were seen as factors facilitating AMS. Participants stressed the importance of a whole
system, consistent approach to AMS and antibiotics within and between organizations and settings
(“singing from the same hymn sheet” (CCG-7, also GP-11 and GP-17)).
I think it’s really important personally to have a multi-pronged approach so that you are all doing
the same thing, and you don’t have a GP saying ‘No, you can’t have an antibiotic’ in their surgery,
and then they walk to the local casualty at 7 pm and come home with Augmentin... It’s trying to have
consistent messages from all areas of the NHS which is the hardest ask. (CCG-8, low-prescribing)
CCG participants reported the crucial role of national NHS leaders in promoting AMS as a national
priority. Few leaders were particularly valued for raising the priority of AMS, influencing targets and
agendas, organizing AMS networks, and acting as sources of helpful information and advice. Similarly,
local AMS leaders and respected experts were seen as helpful in influencing professionals by sharing
information and advice. They were particularly influential when seen as relevant specialists (e.g.,
microbiologists) and peer experts (e.g., GPs); the advice from peers was especially valued as it was
perceived as more feasible in practice, rather than theoretical. Building connections and reputation
within local networks were seen as important and helpful but took time to develop.
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I have to say, the engagement from the Chief Medical Officer (Dame Sally Davies), I think that’s
been very profound and supported what you’re trying to do on the ground. When you have such
high-level leadership, it makes it a lot easier because there’s so many different things on the agenda
of GPs, it’s sometimes hard to fight for space but when you’ve got buy-in at that level and also the
Quality Premium, it makes shifting your thing up the agenda easier. (CCG-4, high-prescribing)
We did a workshop where we got a clinician from another area. It was a doctor who had published
about the work that he’d done in reducing antibiotic prescribing in his surgery and the approach that
they’d taken and we got him to come and talk to all of our practices at a joint locality meeting because
we felt that me standing there going, “you really ought to say no to antibiotics a bit more” probably
wasn’t very helpful but a clinician who had done it, one of their peers was probably more helpful and
that went down really well. (CCG-2, medium-prescribing)
Practice champions were also perceived as critical to quality improvement and practices taking
“ownership of their own prescribing” (CCG-5). It was seen as important for the change to be driven
from within the practices through a whole team approach working towards a common goal and led by
practice leaders and champions. The role of CCG professionals was seen as supporting this process.
. . . if a practice can be united in their approach to managing antimicrobial prescribing, then that
seems to reflect a kind of lower overall antibiotic prescribing rate and that’s true of a lot of prescribing
indicators. If you’ve got people working as a practice and not as a set of individuals, that’s really really
helpful. (CCG-9, multiple CCGs)
It’s something we’ve always been passionate about. Historically we’ve had a few GPs in particular,
two or three of us who strongly believe in antibiotic stewardship. ( . . . ) I think the most important
strategy is creating milieu in the practice to reduce unnecessary prescribing. If you ask me what I
believe personally, you need to be well led. You need to have an environment in the practice that
you’re all buying into that as a principle. And I think if you do that, you’ll be more successful than
if you try to do it unilaterally, on your own sort of thing. You need to try and get buy-in. (GP-6,
low-prescribing)
3.4. Relativity of Appropriate Prescribing
Finally, participants’ views showed that appropriate antibiotic prescribing is, at least partly,
relative and socially constructed as it depends on how it is assessed, what it is compared against,
and on norms and expectations related to antibiotics.
Participants questioned how certain antibiotic prescribing targets and thresholds were identified
and what evidence guided this process, describing them as “arbitrary”. Yet, they were then used
to benchmark CCGs’ and practices’ prescribing, leading to defining some as “high” prescribers.
Prescribing rates were seen as depending on how data was aggregated and averaged. For example,
the apparent high prescribing could be due to including data from higher prescribing organizations
(e.g., out-of-hours) or areas (e.g., with “different demographics” and “historically” different prescribing
rates (CCG-9, multiple CCGs)). It could also be influenced by the prevalence of certain types of patients
(e.g., older, children, with comorbidities) and clinics that may require more antibiotics, and therefore
seen as justified rather than inappropriate.
‘Why have they chosen 10%’? And why this and why that and, ‘They just plucked these figures out of
the air’, so it did create some negative feedback. (CCG-6, high-prescribing)
We’ve put in some arbitrary red, amber, green ratings on the dashboard for our antibiotics, and if
people are green then they’re doing well, they’re performing to target, they’re doing what we want
them to do, they wouldn’t have a great deal of additional scrutiny. If somebody is red and not moving
at all, then that would be more cause for concern. (CCG-8, low-prescribing)
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Perceptions of performance were also relative depending on whether prescribing rates were
compared locally, nationally, or internationally. Being considered to be a high-prescribing CCG was
often seen as relative to other CCGs that had also been improving but without taking into account
different historical prescribing rates and contextual factors. Participants’ reports suggested that
comparisons could motivate some organizations to optimize prescribing. However, they could also
result in complacency (perceiving no need for further improvement) if favorable comparisons were
made, or in disengagement (perceiving improvement as impossible) in cases of large disparity from
targets or others’ performance. There was also a sense that some prescribers may try to circumvent the
targets without optimizing antibiotics if they perceived no value in them.
For us it would be helpful if everybody else would stand still and give us a chance because we are
reducing our antibiotics but equally so is everybody else so whilst we are lower than we were, we are
still higher than other areas . . . . (CCG-2, medium-prescribing)
Being the lowest percentage in the UK is still high when you compare it to other countries in the
world. (GP-6, low-prescribing)
This particular colleague who prescribes a lot of antibiotics used to prescribe a lot of Co-amoxiclav.
Because the CCG are concentrating on that . . . he’s recently moved over to prescribing Azithromycin
. . . He knows that this isn’t one that the CCG are picking up on and paying attention, so it’s a way of
keeping his head down. He wants to prescribe an effective antibiotic which minimizes the risk of the
patient getting worse and needing to be admitted to hospital and that’s his current way of doing it.
(GP-4, high-prescribing)
Participants suggested that social norms around antibiotics and AMS among professionals and
patients are changing. They reported that most healthcare professionals increasingly understand
the importance of AMS and preserving antibiotics as part of good quality care. They described how
most prescribers value feedback about their prescribing and consider adjusting it if it differs from
others or guidelines without good reasons. High prescribers were referred to as “outliers”, “pockets of
resistance” (CCG-1), or “rogues who are doing this inappropriate prescribing” (CCG-3), suggesting that
high prescribing might be increasingly seen as socially unacceptable among professionals and as an
issue of a minority of prescribers and organizations who might be blamed for their higher prescribing.
CCG and practice professionals also described how patients’ awareness of the importance of not taking
antibiotics unnecessarily had increased thanks to public health campaigns and prescribers’ education,
suggesting that wider social norms about antibiotics among patients might be changing.
Generally, now, as prescribers and the general population seem to understand the responsibility that
they have so generally I feel as though I’m pushing against an open door in supporting certainly the
clinicians in trying to achieve appropriate prescribing in their practices. I think maybe that wouldn’t
have been the case 10 or 15 years ago, but I think the perception has changed both in the public and
other healthcare professionals. (CCG-4, high-prescribing)
4. Discussion
Our findings show how antibiotic prescribing and engagement with AMS in general practice in
England is influenced by the social and contextual factors on multiple levels (individual, practice, local,
and national) (Figure 1). Clinicians consider clinical and also social factors when making prescribing
decisions, with variation in socioeconomic factors and health inequalities influencing the (actual and
perceived) need for antibiotics. Moreover, practices that are struggling (e.g., with staff shortages,
demand, and transitions) are seen as unable to engage with AMS, and all practices and CCGs are
described as under pressure with many competing priorities and inadequate resources. In this context,
AMS is seen as an additional burden and lower priority than immediate pressures, and prescribing
antibiotics more freely is a way of dealing with the pressure. Underlying this is the perception of the
Antibiotics 2020, 9, 859 11 of 15
arbitrariness of prescribing targets and data, and relativity of “appropriate” antibiotic prescribing and
comparisons of prescribing rates. While targets and data are important change facilitators, in some
situations they may be met with complacency, despondency, or disregard. Changing social norms and
expectations about antibiotics mean that healthcare professionals and patients are increasingly aware
of and perceive the importance of not using antibiotics unnecessarily. Participants believed that AMS
and prudent prescribing may be encouraged by the following: tailoring of AMS initiatives to local
contexts, ensuring acceptability and feasibility of AMS strategies that fit within situational constraints,
leadership and teamwork, time for AMS, and a whole system approach to promote consistency and
address wider health inequalities.
4.1. Comparison with the Literature
Socioeconomic deprivation has been linked with a higher prevalence of antibiotics in primary
care across England [21], Scotland [22], Wales [23], and Northern Ireland [24], even after controlling for
patient demographics, smoking, and chronic conditions. We found that deprived and ethnic minority
populations were perceived as needing more antibiotics, as clinicians consider the wider context of
patients’ lives, such as their (perceived) ability to self-care, reconsult if needed, risk of complications,
and the impact of not working. This illustrates the role of perceptions of general practice clinicians in
considering and treating patients holistically [25]. Participants also suggested that higher prescribing
might be more likely in situations when explaining non-prescribing decisions to patients is difficult,
for example, due to cultural understandings and spoken languages. While perceptions of patient
expectations may be misinterpreted [26,27], research on how expectations for antibiotics may vary
among different populations in England is lacking.
Substantial variability in antibiotic prescribing between practices remains unexplained by
individual-level variables, with a wide variation in prescribing to less unwell patients, suggesting
practice and prescriber factors [9,10,28]. Higher rates of antibiotics have also been correlated with
more prescribing of other medicines [29]. Therefore, as we found, higher antibiotic prescribing
might be indicative of some practice characteristics and contextual factors. Previous studies have
found higher antibiotic prescribing to be associated with larger practices [7], non-training practices,
shorter appointments, and GPs who were male, over 45 years old, and qualified outside the UK [12].
A qualitative study also found consultation length, triage system, and access to microbiologists or
pharmacists to be perceived by GPs as influencing prescribing [17]. Additionally, we identified
the influence of staff turnover and temporality, workload, competing priorities, and insufficient
resources. In the pressured context, antibiotic (over)prescribing may be seen as a rational response to
the circumstances (as found in hospitals [30]). With the perceived constant pressure on prescribers
to change but no conducive change in the context, we found that there was a sense that further
considerable change might be unrealistic. On the contrary, we found that practice culture and a
wider context of good communication, teamwork, and leadership may facilitate better prescribing and
engagement with AMS.
Our findings highlight the role of AMS leaders and networks in sharing information, learning
from each other’s experience, and raising the priority of AMS. Collaboration across professions,
organizations, and settings, as well as a whole system approach was seen as needed to promote greater
consistency in antibiotic prescribing. These findings are reflected in a survey of all CCGs which also
found the perceived importance of relevant experts and champions and a whole practice, system
wide approach [31,32], and challenges caused by insufficient time and other resources dedicated
to AMS [33]. Leadership and championing, involvement in networks, and developing trusting,
respectful relationships takes time. Ensuring adequate time and other resources is important for CCG
professionals (acting as intermediaries supporting GPs [34]), and for practice professionals who may
experience tensions between their clinical and leadership roles [35].
The influence of antibiotic-related social norms and perceived relativity of targets and comparisons
were also apparent. Perceptions of others’ prescribing and support for no-antibiotic decisions seem
Antibiotics 2020, 9, 859 12 of 15
to differentiate between low- and high-prescribing practices [17]. We also found that perceived lack
of consistency may increase unnecessary prescribing to avoid patients re-consulting with another
doctor or service (thus helping reduce workload). Moreover, we find that “appropriate” or “high”
antibiotic prescribing is seen as relative as it depends on a comparator. Feedback on prescribing and
benchmarking and comparing with other practices can influence social norms and help optimize
antibiotics [18,32,36]. However, we found that in some cases it could also lead to complacency, despite a
potential for optimizing antibiotics if compared to other reference points. It may also lead to disregard
or disengagement, especially if targets are perceived as unachievable [18] or differences from others
as too big [37]. Our participants highlighted that the sole focus on benchmarking does not take into
account the different local contexts and changes that have been achieved within these. However,
they reported that the wider social norms among professionals and patients related to appropriate
antibiotic use have started to shift. Over time, this might help change the UK’s culture of high antibiotic
prescribing to a “norm” to withhold antibiotics rather than prescribe [38].
Finally, despite many challenges, improvement in antibiotic prescribing (including high prescribers)
needs acknowledging. Since the introduction of the QP antibiotic prescribing measures, most CCGs
have met the targets [4]; moreover, the highest prescribing practices have reduced their antibiotic
prescribing at a higher rate [39], and the variation across practices has been declining [7]. Therefore,
now the focus needs to be on further supporting prescribers, practices, and commissioners in these
improvements, and on reducing health inequalities by tailoring the support to the specific contexts
and needs.
4.2. Implications
Figure 1 includes examples of possible implications for how the identified influences might be
addressed to support antibiotic optimization. More research is needed to identify (novel) ways to
address the interpersonal, organizational, and system-level influences on antibiotic use and health
inequalities. More focus is also needed on how to adapt and implement existing interventions in ways
that take into account the local context and fit within constraints (e.g., concise, with clear benefits).
Adequate support and resources for CCGs and general practices would enable professionals to take
time to focus on AMS. CCG professionals require more staff time and guidance to engage with practices
more and provide support tailored to practice context and needs (e.g., to identify and address particular
reasons for high prescribing). They may also be able to promote and reinforce antibiotic optimization
among lower prescribers to sustain and make further improvements. Providing resources, such as
protected time and additional funding, could mitigate some barriers and support AMS leaders and
champions in CCGs and practices. A whole system approach (e.g., by involving leaders and networks
across organizations and disciplines) is needed to promote consistency in prudent antibiotic prescribing
and to address socioeconomic and health inequalities.
4.3. Limitations
Purposeful sampling to ensure variation was planned but not possible; eventually, the final
pragmatic sample was still relatively diverse and included CCGs and practices with a range of
antibiotic prescribing levels, deprivation, and size. We included in the study all participants who
expressed interest and agreed to participate; their views might have differed from those who did not
volunteer to participate. As with all qualitative studies, the findings are time and context specific.
5. Conclusions
Although antibiotic prescribing is an individual behavior, influenced by individual-level factors,
social and contextual factors also impact prescribing. Deprivation, staff shortages and turnover,
insufficient resources, and competing priorities were perceived as the main contextual barriers to
prudent prescribing and engagement with AMS. Tailoring to local contexts, adequate resources,
collaboration and teamwork, multidisciplinary networks, strong AMS leadership, and social norms
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among professionals and patients conducive to appropriate antibiotic use were seen as helping
AMS promotion and engagement. Antibiotics will likely continue to be prescribed unnecessarily
or inappropriately without changes in the context of prescribing, and without adequate time and
resources to support accurate diagnosis and appropriate prescribing. Further optimization of antibiotic
prescribing in primary care requires interventions and solutions that go beyond targeting individual
behavior change and address social and contextual influences.
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